PORTLAND, Ore., Sept. 26, 2018 /PRNewswire/ — Aronora Inc., a
Read moreAronora’s New Blood Clot Treatment proCase Receives FDA Fast Track Designation
Home »
FDA Approves Nuzyra
BOSTON, Oct. 02, 2018 (GLOBE NEWSWIRE) — Paratek Pharmaceuticals, Inc.
Read moreER staffers under assault. Blame the opioid crisis.
(HealthDay)—Emergency departments are becoming increasingly violent places as doctors bear
Read moreLow self-esteem connected to greater risk for opioid use
Health, family and romance problems appear to be the particular
Read morePharmaceutical executive defends 400 percent price hike
(HealthDay)—A pharmaceutical executive is defending his company’s 400 percent price
Read moreAbbVie Announces Patient-Reported Outcomes Data from Three Pivotal Phase 3 Studies of Risankizumab, Showing Significant Improvements in Health-Related Quality of Life for Patients with Psoriasis
NORTH CHICAGO, Ill., Sept. 13, 2018 /PRNewswire/ — AbbVie (NYSE:
Read moreBristol-Myers Squibb’s Novel, Oral, Selective TYK2 Inhibitor Delivered Significant Skin Clearance in Patients with Moderate to Severe Plaque Psoriasis in Phase 2 Trial
PRINCETON, N.J.–(BUSINESS WIRE)– September 12, 2018 — Bristol-Myers Squibb Company
Read moreFDA Approves Xelpros
MUMBAI, India & PRINCETON, N.J.–(BUSINESS WIRE) September 14, 2018 –Sun
Read moreThe entire truth about THINKING
Regrettably, I might have to break someone`s child`s psyche, however
Read morePoorest Americans most likely to have used prescription opioids—and most users view opioids positively
Among older Americans, the poorest are the most likely to
Read more